Limit search to items available for checkout
E-BOOK
Title Medical isotope production without highly enriched uranium / Committee on Medical Isotope Production Without Highly Enriched Uranium, Nuclear and Radiation Studies Board, Division of Earth and Life Studies, National Research Council of the National Academies.
Imprint Washington, D.C. : National Academies Press, ©2009.

Copies/Volumes

LOCATION CALL # STATUS
 Internet  Electronic Book    AVAILABLE
Description 1 online resource (xviii, 202 pages)
Note Title from electronic title page (viewed June 1, 2009).
Bibliog. Includes bibliographical references.
Note Available only to authorized UTEP users.
Sponsored by the National Academy of Sciences and the U.S. Department of Energy DE-AM01-04PI45013
English.
Subject Uranium -- Isotopes.
Uranium -- Isotopes -- Therapeutic use.
Highly enriched uranium -- Isotopes -- Therapeutic use.
Molybdenum -- Isotopes -- Therapeutic use.
Technetium -- Isotopes -- Therapeutic use.
Radioisotopes -- Therapeutic use.
Nuclear medicine -- Standards -- United States.
Molybdenum -- supply & distribution -- United States.
Molybedenum -- isolation & purification -- United States.
Radioisotopes -- supply & distribution -- United States.
Technetium Compounds -- isolation & purification -- United States.
Diagnostic Imaging -- United States.
Radionuclide Generators -- United States.
Quality Control -- United States.
United States.
Genre Electronic books.
Contents Background and study task -- Molybdenum-99/Technetium-99m production and use -- Molybdenum-99/Technetium-99m supply -- Molybdenum-99/Technetium-99m supply reliability -- Molybdenum-99/Technetium-99m demand -- Molybdenum-99/Technetium-99m production costs -- Conversion to LEU-based production of Molybdenum-99: technical considerations -- Conversion to LEU-based production of Molybdenum-99: regulatory considerations -- Conversion to LEU-based production of Molybdenum-99: general approaches and timing -- Conversion to LEU-based production of Molybdenum-99: prospects and feasibility.
Summary "This book is the product of a congressionally mandated study to examine the feasibility of eliminating the use of highly enriched uranium (HEU2) in reactor fuel, reactor targets, and medical isotope production facilities. The book focuses primarily on the use of HEU for the production of the medical isotope molybdenum-99 (Mo-99), whose decay product, technetium-99m3 (Tc-99m), is used in the majority of medical diagnostic imaging procedures in the United States, and secondarily on the use of HEU for research and test reactor fuel. The supply of Mo-99 in the U.S. is likely to be unreliable until newer production sources come online. The reliability of the current supply system is an important medical isotope concern; this book concludes that achieving a cost difference of less than 10 percent in facilities that will need to convert from HEU- to LEU-based Mo-99 production is much less important than is reliability of supply."
Other Author National Research Council (U.S.). Committee on Medical Isotope Production Without Highly Enriched Uranium.
Other Title Print version: Washington, D.C. : National Academies Press, ©2009